ABCC8 and Hypoglycemia: Unlike sulfonylureas, repaglinide exhibits rapid dissociation from the sulfonylurea receptor 1 (SUR1) subunit of the K-ATP channel, which may reduce the risk of prolonged hypoglycemia and allow for a more flexible dosing regimen based on meals [144].